Symbol | YTM % | Volume | Price % | Coupon % | Maturity date | Outstanding amt | Face value | Min denom amt | Issuer |
---|---|---|---|---|---|---|---|---|---|
6.89% | 1.35 M | 65.75% | 3.18% | 2050-07-09 | 2 B USD | 1,000.00 USD | 200,000.00 USD | Takeda Pharmaceutical Co., Ltd. | |
6.73% | 500 K | 64.91% | 3.38% | 2060-07-09 | 1 B USD | 1,000.00 USD | 200,000.00 USD | Takeda Pharmaceutical Co., Ltd. | |
6.22% | 5.7 M | 74.98% | 3.03% | 2040-07-09 | 1.5 B USD | 1,000.00 USD | 200,000.00 USD | Takeda Pharmaceutical Co., Ltd. | |
5.92% | 15 M | 98.54% | 5.80% | 2064-07-05 | 500 M USD | 1,000.00 USD | 200,000.00 USD | Takeda Pharmaceutical Co., Ltd. | |
TTKPH4369980Baxalta Incorporated 5.25% 23-JUN-2045 | 5.83% | 278 K | 94.65% | 5.25% | 2045-06-23 | 500.41 M USD | 1,000.00 USD | 2,000.00 USD | Baxalta, Inc. |
5.80% | 5.2 M | 98.40% | 5.65% | 2054-07-05 | 600 M USD | 1,000.00 USD | 200,000.00 USD | Takeda Pharmaceutical Co., Ltd. | |
5.65% | 100 K | 100.03% | 5.65% | 2044-07-05 | 800 M USD | 1,000.00 USD | 200,000.00 USD | Takeda Pharmaceutical Co., Ltd. | |
5.04% | 3 M | 101.66% | 5.30% | 2034-07-05 | 1.1 B USD | 1,000.00 USD | 200,000.00 USD | Takeda Pharmaceutical Co., Ltd. | |
4.99% | 4.55 M | 88.25% | 2.05% | 2030-03-31 | 2.5 B USD | 1,000.00 USD | 200,000.00 USD | Takeda Pharmaceutical Co., Ltd. | |
TTKPH4370840Baxalta Incorporated 4.0% 23-JUN-2025 | 4.92% | 538 K | 99.80% | 4.00% | 2025-06-23 | 800.17 M USD | 1,000.00 USD | 2,000.00 USD | Baxalta, Inc. |
4.63% | 0 | 76.44% | 2.00% | 2040-07-09 | 1 B EUR | 1,000.00 EUR | 100,000.00 EUR | Takeda Pharmaceutical Co., Ltd. | |
UUS82481LAD1SHIRE ACQUIST.I.IE 16/26 | 4.63% | 0 | 98.03% | 3.20% | 2026-09-23 | 1.5 B USD | 1,000.00 USD | 2,000.00 USD | Shire Acquisitions Investments Ireland DAC |
4.56% | 150 K | 101.37% | 5.00% | 2028-11-26 | 1.73 B USD | 1,000.00 USD | 200,000.00 USD | Takeda Pharmaceutical Co., Ltd. | |
3.57% | 0 | 87.30% | 1.38% | 2032-07-09 | 1 B EUR | 1,000.00 EUR | 100,000.00 EUR | Takeda Pharmaceutical Co., Ltd. | |
3.17% | 0 | 99.17% | 3.00% | 2030-11-21 | 1.5 B EUR | 1,000.00 EUR | 100,000.00 EUR | Takeda Pharmaceutical Co., Ltd. | |
3.05% | 0 | 92.27% | 1.00% | 2029-07-09 | 850 M EUR | 1,000.00 EUR | 100,000.00 EUR | Takeda Pharmaceutical Co., Ltd. | |
2.74% | 0 | 95.76% | 0.75% | 2027-07-09 | 750 M EUR | 1,000.00 EUR | 100,000.00 EUR | Takeda Pharmaceutical Co., Ltd. | |
2.71% | 0 | 116.57% | 5.00% | 2028-11-26 | 22.68 M USD | 1,000.00 USD | 200,000.00 USD | Takeda Pharmaceutical Co., Ltd. | |
2.60% | 0 | 99.45% | 2.25% | 2026-11-21 | 1.5 B EUR | 1,000.00 EUR | 100,000.00 EUR | Takeda Pharmaceutical Co., Ltd. | |
SSHPG4260178Baxalta Incorporated 4.0% 23-JUN-2025 | — | — | — | 4.00% | 2025-06-23 | 303 K USD | 1,000.00 USD | 2,000.00 USD | Baxalta, Inc. |
— | — | — | 5.00% | 2028-11-26 | 22.68 M USD | 1,000.00 USD | 200,000.00 USD | Takeda Pharmaceutical Co., Ltd. |